Amentum (NYSE:AMTM) Rating Lowered to “Hold” at Wall Street Zen

Amentum (NYSE:AMTM – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday, Wall Street Zen reports.

Several other research analysts have also commented on AMTM. Royal Bank Of Canada reduced their price target on Amentum from $26.00 to $25.00 and set a “sector perform” rating for the company in a research report on Wednesday, October 28th. The Goldman Sachs Group set a $24.00 price target on shares of Amentum in a research note on Thursday, August 20th. Bank of America reduced their price target on Amentum from $35.00 to $30.00 and set a “neutral” rating on the stock in a research report on Monday, July 20th. UBS Group upped their price target on shares of Amentum from $23.00 to $24.00 and gave the company a “neutral” rating in a research report on Wednesday, August 12th. Finally, Weiss Ratings raised Amentum from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday. Five investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $28.91.

Get Our Latest Research Report on Amentum

Amentum Stock Down 1.1%

NYSE AMTM opened at $21.82 on Friday. The business’s 50-day moving average is $19.82 and its 200 day moving average is $24.57. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.52 and a quick ratio of 1.52. The stock has a market capitalization of $5.34 billion, a PE ratio of 26.29, a PEG ratio of 0.59 and a beta of 0.14. Amentum has a 1 year low of $17.72 and a 1 year high of $38.11.

Amentum (NYSE:AMTM – Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The company reported $0.67 EPS for the quarter, beating analysts’ consensus estimates of $0.61 by $0.06. Amentum had a net margin of 1.44% and a return on equity of 12.19%. The firm had revenue of $3.49 billion for the quarter, compared to analysts’ expectations of $3.57 billion. During the same quarter in the prior year, the company posted $0.56 earnings per share. The business’s revenue for the quarter was down 2.0% on a year-over-year basis. Amentum has set its FY 2026 guidance at 2.400-2.500 EPS. Sell-side analysts forecast that Amentum will post 2.38 earnings per share for the current year.

Institutional Investors Weigh In On Amentum

A number of institutional investors have recently made changes to their positions in the company. BlackRock Inc. acquired a new position in shares of Amentum during the second quarter valued at $370,137,000. Bank of America Corp DE raised its holdings in shares of Amentum by 107.8% during the 1st quarter. Bank of America Corp DE now owns 2,405,041 shares of the company’s stock valued at $62,723,000 after purchasing an additional 1,247,614 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Amentum during the 2nd quarter worth $18,150,000. Bryn Mawr Trust Advisors LLC bought a new stake in shares of Amentum in the second quarter valued at approximately $2,924,000. Finally, Troluce Capital Advisors LLC bought a new stake in Amentum in the 1st quarter valued at $26,080,000. 39.93% of the stock is currently owned by institutional investors.

About Amentum

(Get Free Report)

Amentum (NYSE: AMTM) is a government-focused engineering and technical services company that supports national security, defense, space, intelligence, energy and environmental missions. Its services include systems engineering, program management, operations and maintenance, logistics, cybersecurity, information technology, scientific research and testing, and mission support.

The company serves government customers in the United States and internationally, supporting complex programs and critical infrastructure across areas such as defense, nuclear security, aerospace, civil engineering and environmental remediation.

Featured Articles

Analyst Recommendations for Amentum (NYSE:AMTM)

Receive News & Ratings for Amentum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amentum and related companies with MarketBeat.com's FREE daily email newsletter.